newsfilter
← Latest News
PR Newswire·

Medivir to present at the Redeye Growth Day

STOCKHOLM, June 1, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company